======= PPID =======
== Gene Information ==
* **Official Symbol**: PPID
* **Official Name**: peptidylprolyl isomerase D
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5481|5481]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q08752|Q08752]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PPID&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PPID|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601753|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. Proposed to act as a co-chaperone in HSP90 complexes such as in unligated steroid receptors heterocomplexes. Different co-chaperones seem to compete for association with HSP90 thus establishing distinct HSP90-co-chaperone-receptor complexes with the potential to exert tissue-specific receptor activity control. May have a preference for estrogen receptor complexes and is not found in glucocorticoid receptor complexes. May be involved in cytoplasmic dynein-dependent movement of the receptor from the cytoplasm to the nucleus. May regulate MYB by inhibiting its DNA- binding activity. Involved in regulation of AHR signaling by promoting the formation of the AHR:ARNT dimer; the function is independent of HSP90 but requires the chaperone activity. Involved in regulation of UV radiation-induced apoptosis. Promotes cell viability in anaplastic lymphoma kinase-positive anaplastic large- cell lymphoma (ALK+ ALCL) cell lines. May be involved in hepatitis C virus (HCV) replication and release. {ECO:0000269|PubMed:11350175, ECO:0000269|PubMed:18708059, ECO:0000269|PubMed:19932913, ECO:0000269|PubMed:21711559, ECO:0000269|PubMed:22681779, ECO:0000269|PubMed:23220213, ECO:0000269|PubMed:9659917}.
|Pro isomerase|
|cellular response to UV-A|
|viral release from host cell|
|response to UV-A|
|exit from host|
|movement in environment of other organism involved in symbiotic interaction|
|movement in host environment|
|exit from host cell|
|lipid droplet organization|
|cyclosporin A binding|
|positive regulation of viral genome replication|
|protein refolding|
|Hsp90 protein binding|
|Hsp70 protein binding|
|estrogen receptor binding|
|peptidyl-prolyl cis-trans isomerase activity|
|protein peptidyl-prolyl isomerization|
|chaperone-mediated protein folding|
|heat shock protein binding|
|peptidyl-proline modification|
|positive regulation of viral life cycle|
|cellular response to UV|
|regulation of viral genome replication|
|positive regulation of viral process|
|cellular response to light stimulus|
|unfolded protein binding|
|response to UV|
|regulation of viral life cycle|
|interaction with host|
|cellular response to radiation|
|viral life cycle|
|regulation of viral process|
|regulation of symbiosis, encompassing mutualism through parasitism|
|protein folding|
|positive regulation of protein secretion|
|positive regulation of peptide secretion|
|response to light stimulus|
|cellular response to abiotic stimulus|
|cellular response to environmental stimulus|
|transcription factor binding|
|positive regulation of secretion by cell|
|positive regulation of protein transport|
|positive regulation of secretion|
|response to radiation|
|positive regulation of establishment of protein localization|
|regulation of protein secretion|
|regulation of peptide secretion|
|positive regulation of multi-organism process|
|positive regulation of apoptotic process|
|positive regulation of programmed cell death|
|positive regulation of cell death|
|viral process|
|regulation of protein transport|
|regulation of peptide transport|
|regulation of establishment of protein localization|
|regulation of secretion by cell|
|regulation of multi-organism process|
|symbiotic process|
|regulation of secretion|
|interspecies interaction between organisms|
|nucleolus|
|negative regulation of transcription by RNA polymerase II|
|peptidyl-amino acid modification|
|apoptotic process|
|positive regulation of transport|
|regulation of protein localization|
|programmed cell death|
|cell death|
|response to abiotic stimulus|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|locomotion|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|protein transport|
|negative regulation of cellular biosynthetic process|
|peptide transport|
|regulation of apoptotic process|
|negative regulation of biosynthetic process|
|protein-containing complex assembly|
|regulation of programmed cell death|
|amide transport|
|establishment of protein localization|
|regulation of cell death|
|negative regulation of gene expression|
|nitrogen compound transport|
|protein-containing complex subunit organization|
|regulation of transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.81|
|[[:results:exp10|CCCP 0.1μM R00 exp10]]|1.86|
|[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|1.94|
|[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|2.06|
|[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|2.12|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.507|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15544
* **Expression level (log2 read counts)**: 5.43
{{:chemogenomics:nalm6 dist.png?nolink |}}